MetaCap

Citius Oncology (CTOR) News

NASDAQ: CTORHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.5035-0.0619 (-10.95%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CTOR news summary

We found 1 recent headline mentioning Citius Oncology (CTOR): 0 in the past week and 1 in the past 30 days, most often from PR Newswire. CTOR is making an outsized move today, down 10.95% at $0.5035, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Citius Oncology Reports Continued Institutional Demand and 120% Growth in Shipments of LYMPHIR® Units to U.S. Wholesalers During the Fiscal Fourth Quarter of 2026", was published by PR Newswire on Oct 26, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Citius Oncology headlines

Stocks mentioned alongside CTOR

Compare CTOR